(The following press release from Merck Serono was received by e-mail. It 
was not confirmed by the sender.) 
News Release 
Your Contact
Heather Connor
+1 978-294-1660 
Merck Serono and Quintiles Announce Innovative Clinical Development
• Agreement creates unique strategic collaboration for development and
 clinical trial execution 
Darmstadt, Germany, May 15, 2013 – Merck Serono, a division of Merck,
Darmstadt, Germany, and Quintiles, the world’s largest provider of
biopharmaceutical development and commercial outsourcing services, today
announced a new, five-year clinical development agreement. This strategic
collaboration is the first-of-its-kind between a biopharmaceutical company
and a biopharmaceutical services provider, creating a comprehensive process
that integrates the expertise and experience from both organizations into a
single, well-aligned clinical development engine. 
The complete news release can be downloaded at the following link:$File/MerckSerono_Quin
News releases from Merck KGaA, Darmstadt, Germany, are available at this
address: or for residents in the USA and Canada at 
In case you are a resident of the USA or Canada please go to to register again for your online
subscription of this service as our newly introduced geo-targeting requires
new links in the email. 
You may change your subscription at any time by following either one of the
following links: or
And please feel free to unsubscribe this service with either or
Thank you very much! 
Merck KGaA ,Darmstadt, Germany
External Communications
Hotline: +49 (0) 6151/72-5000 
This message and any attachment are confidential and may be privileged or
otherwise protected from disclosure. If you are not the intended recipient,
you must not copy this message or attachment or disclose the contents to
any other person. If you have received this transmission in error, please
notify the sender immediately and delete the message and any attachment
from your system. Merck KGaA, Darmstadt, Germany and any of its
subsidiaries do not accept liability for any omissions or errors in this
message which may arise as a result of E-Mail-transmission or for damages
resulting from any unauthorized changes of the content of this message and
any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its
subsidiaries do not guarantee that this message is free of viruses and does
not accept liability for any damages caused by any virus transmitted
Click to access the German, French, Spanish and
Portuguese versions of this disclaimer.
Press spacebar to pause and continue. Press esc to stop.